cd62 e p Search Results


anti human p selectin antibody  (R&D Systems)
94
R&D Systems anti human p selectin antibody
Quantitative evaluation of <t>P-selectin</t> and ICAM-1 expression on rat mesenteric microvessels 24 h after intravenous injection of E. coli . SHAM, sham-operated rats; NT, non-treated rats; LR, lactated Ringer's solution (4 mL/kg)-treated rats; REP (4 mL/Kg LR + 50 mg/kg ethyl pyruvate)-treated rats. The presented values are the mean ± SEM for 3 samples/rat, with 3 rats/group. The analyses were performed using NIS-Elements BR software (Nikon). The results are presented as objectsx10 3 /μm 2 . * p <0.001 versus SHAM, § p <0.01 versus SHAM and NT, † p <0.001 versus NT, ? p <0.01 versus LR.
Anti Human P Selectin Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+Antibody/pmc04496755-87-15-19
Average 94 stars, based on 1 article reviews
anti human p selectin antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
cd62 e p  (R&D Systems)
93
R&D Systems cd62 e p
EV surface marker changes after RIC treatment: The expression of the EV-markers <t>CD62</t> and MCP-1 is plotted showing the Log 2 fold changes compared to the baseline sample of each patient. The p-value is shown for both the significant changes within RIC group (red) and compared with the miRNA expression changes over time in Sham group (grey). ( a ) CD62 shows an upregulation in RIC treated patients compared to Sham. ( b ) MCP-1 showed no significant changes in between the different timepoints
Cd62 E P, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+Antibody/pmc12888686-3-0-3
Average 93 stars, based on 1 article reviews
cd62 e p - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
human e-selectin/p-selectin (cd62e/p) pe-conjugated antibody  (Bio-Techne corporation)
90
Bio-Techne corporation human e-selectin/p-selectin (cd62e/p) pe-conjugated antibody
EV surface marker changes after RIC treatment: The expression of the EV-markers <t>CD62</t> and MCP-1 is plotted showing the Log 2 fold changes compared to the baseline sample of each patient. The p-value is shown for both the significant changes within RIC group (red) and compared with the miRNA expression changes over time in Sham group (grey). ( a ) CD62 shows an upregulation in RIC treated patients compared to Sham. ( b ) MCP-1 showed no significant changes in between the different timepoints
Human E Selectin/P Selectin (Cd62e/P) Pe Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+PE-conjugated+Antibody/bio-techne+corporation___fab6169p
Average 90 stars, based on 1 article reviews
human e-selectin/p-selectin (cd62e/p) pe-conjugated antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti human p selectin  (R&D Systems)
94
R&D Systems anti human p selectin
( A – C <t>):</t> <t>P-selectin</t> expression on unstimulated ( A ), ADP-stimulated ( B ), and TRAP-stimulated ( C ) platelets of patients with sepsis and septic shock compared to healthy controls at T0, T1, and T2. Results are expressed as a % of P-selectin-positive platelets, identified as CD42 B-positive events. ( A ) T0 vs. CTRL: p bonf = 0.0006; T1 vs. CTRL: p bonf = 0.0006; T2 vs. CTRL: p bonf = 0.12; ( B ) T0 vs. CTRL: p bonf = 0.026; T1 vs. CTRL: p bonf = 0.056; T2 vs. CTRL: p bonf = 0.037; ( C ) n.s.= not significant. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are reported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05, ** p < 0.005. ns = no significance.
Anti Human P Selectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+APC-conjugated+Antibody/pmc12943321-106-14-16
Average 94 stars, based on 1 article reviews
anti human p selectin - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
human e-selectin/p-selectin (cd62e/p) fluorescein-conjugated antibody  (Bio-Techne corporation)
90
Bio-Techne corporation human e-selectin/p-selectin (cd62e/p) fluorescein-conjugated antibody
( A – C <t>):</t> <t>P-selectin</t> expression on unstimulated ( A ), ADP-stimulated ( B ), and TRAP-stimulated ( C ) platelets of patients with sepsis and septic shock compared to healthy controls at T0, T1, and T2. Results are expressed as a % of P-selectin-positive platelets, identified as CD42 B-positive events. ( A ) T0 vs. CTRL: p bonf = 0.0006; T1 vs. CTRL: p bonf = 0.0006; T2 vs. CTRL: p bonf = 0.12; ( B ) T0 vs. CTRL: p bonf = 0.026; T1 vs. CTRL: p bonf = 0.056; T2 vs. CTRL: p bonf = 0.037; ( C ) n.s.= not significant. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are reported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05, ** p < 0.005. ns = no significance.
Human E Selectin/P Selectin (Cd62e/P) Fluorescein Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+Fluorescein-conjugated+Antibody/bio-techne+corporation___fab6169f
Average 90 stars, based on 1 article reviews
human e-selectin/p-selectin (cd62e/p) fluorescein-conjugated antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
fluorescein conjugated mouse monoclonal antihuman e selectin  (R&D Systems)
90
R&D Systems fluorescein conjugated mouse monoclonal antihuman e selectin
( A – C <t>):</t> <t>P-selectin</t> expression on unstimulated ( A ), ADP-stimulated ( B ), and TRAP-stimulated ( C ) platelets of patients with sepsis and septic shock compared to healthy controls at T0, T1, and T2. Results are expressed as a % of P-selectin-positive platelets, identified as CD42 B-positive events. ( A ) T0 vs. CTRL: p bonf = 0.0006; T1 vs. CTRL: p bonf = 0.0006; T2 vs. CTRL: p bonf = 0.12; ( B ) T0 vs. CTRL: p bonf = 0.026; T1 vs. CTRL: p bonf = 0.056; T2 vs. CTRL: p bonf = 0.037; ( C ) n.s.= not significant. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are reported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05, ** p < 0.005. ns = no significance.
Fluorescein Conjugated Mouse Monoclonal Antihuman E Selectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+Fluorescein-conjugated+Antibody/10__1021_slash_la904678p-82-16-34
Average 90 stars, based on 1 article reviews
fluorescein conjugated mouse monoclonal antihuman e selectin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pe conjugated mouse anti human e selectin  (R&D Systems)
90
R&D Systems pe conjugated mouse anti human e selectin
( A – C <t>):</t> <t>P-selectin</t> expression on unstimulated ( A ), ADP-stimulated ( B ), and TRAP-stimulated ( C ) platelets of patients with sepsis and septic shock compared to healthy controls at T0, T1, and T2. Results are expressed as a % of P-selectin-positive platelets, identified as CD42 B-positive events. ( A ) T0 vs. CTRL: p bonf = 0.0006; T1 vs. CTRL: p bonf = 0.0006; T2 vs. CTRL: p bonf = 0.12; ( B ) T0 vs. CTRL: p bonf = 0.026; T1 vs. CTRL: p bonf = 0.056; T2 vs. CTRL: p bonf = 0.037; ( C ) n.s.= not significant. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are reported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05, ** p < 0.005. ns = no significance.
Pe Conjugated Mouse Anti Human E Selectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+PE-conjugated+Antibody/pmc03482611-177-39-52
Average 90 stars, based on 1 article reviews
pe conjugated mouse anti human e selectin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human e-selectin/p-selectin (cd62e/p) apc-conjugated antibody  (Bio-Techne corporation)
92
Bio-Techne corporation human e-selectin/p-selectin (cd62e/p) apc-conjugated antibody
( A – C <t>):</t> <t>P-selectin</t> expression on unstimulated ( A ), ADP-stimulated ( B ), and TRAP-stimulated ( C ) platelets of patients with sepsis and septic shock compared to healthy controls at T0, T1, and T2. Results are expressed as a % of P-selectin-positive platelets, identified as CD42 B-positive events. ( A ) T0 vs. CTRL: p bonf = 0.0006; T1 vs. CTRL: p bonf = 0.0006; T2 vs. CTRL: p bonf = 0.12; ( B ) T0 vs. CTRL: p bonf = 0.026; T1 vs. CTRL: p bonf = 0.056; T2 vs. CTRL: p bonf = 0.037; ( C ) n.s.= not significant. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are reported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05, ** p < 0.005. ns = no significance.
Human E Selectin/P Selectin (Cd62e/P) Apc Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd62+e+p/Human+E-Selectin%2FP-Selectin+(CD62E%2FP)+APC-conjugated+Antibody/bio-techne+corporation___fab6169a
Average 92 stars, based on 1 article reviews
human e-selectin/p-selectin (cd62e/p) apc-conjugated antibody - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
cd62e antibody  (Biosynth Carbosynth)
N/A
CD62E antibody (PE) was raised in mouse using human CD62E/E-selectin as the immunogen. Mouse monoclonal CD62E antibody (PE).
   Buy from Supplier

Image Search Results


Quantitative evaluation of P-selectin and ICAM-1 expression on rat mesenteric microvessels 24 h after intravenous injection of E. coli . SHAM, sham-operated rats; NT, non-treated rats; LR, lactated Ringer's solution (4 mL/kg)-treated rats; REP (4 mL/Kg LR + 50 mg/kg ethyl pyruvate)-treated rats. The presented values are the mean ± SEM for 3 samples/rat, with 3 rats/group. The analyses were performed using NIS-Elements BR software (Nikon). The results are presented as objectsx10 3 /μm 2 . * p <0.001 versus SHAM, § p <0.01 versus SHAM and NT, † p <0.001 versus NT, ? p <0.01 versus LR.

Journal: Clinics

Article Title: Effects of ethyl pyruvate on leukocyte-endothelial interactions in the mesenteric microcirculation during early sepsis treatment

doi: 10.6061/clinics/2015(07)08

Figure Lengend Snippet: Quantitative evaluation of P-selectin and ICAM-1 expression on rat mesenteric microvessels 24 h after intravenous injection of E. coli . SHAM, sham-operated rats; NT, non-treated rats; LR, lactated Ringer's solution (4 mL/kg)-treated rats; REP (4 mL/Kg LR + 50 mg/kg ethyl pyruvate)-treated rats. The presented values are the mean ± SEM for 3 samples/rat, with 3 rats/group. The analyses were performed using NIS-Elements BR software (Nikon). The results are presented as objectsx10 3 /μm 2 . * p <0.001 versus SHAM, § p <0.01 versus SHAM and NT, † p <0.001 versus NT, ? p <0.01 versus LR.

Article Snippet: The sections were then incubated overnight in a humidified chamber (4°C) with either a monoclonal anti-human P-selectin antibody (CD62P; R&D Systems Inc, Minneapolis, MN, USA) or a monoclonal anti-rat ICAM-1 antibody (CD54; Cedarlane Laboratories, Ontario, Canada).

Techniques: Expressing, Injection, Software

EV surface marker changes after RIC treatment: The expression of the EV-markers CD62 and MCP-1 is plotted showing the Log 2 fold changes compared to the baseline sample of each patient. The p-value is shown for both the significant changes within RIC group (red) and compared with the miRNA expression changes over time in Sham group (grey). ( a ) CD62 shows an upregulation in RIC treated patients compared to Sham. ( b ) MCP-1 showed no significant changes in between the different timepoints

Journal: BMC Neuroscience

Article Title: Exploring extracellular vesicle surface markers and microRNA regulation following remote ischemic conditioning in patients with stroke; a randomized-controlled pilot study

doi: 10.1186/s12868-025-00993-1

Figure Lengend Snippet: EV surface marker changes after RIC treatment: The expression of the EV-markers CD62 and MCP-1 is plotted showing the Log 2 fold changes compared to the baseline sample of each patient. The p-value is shown for both the significant changes within RIC group (red) and compared with the miRNA expression changes over time in Sham group (grey). ( a ) CD62 shows an upregulation in RIC treated patients compared to Sham. ( b ) MCP-1 showed no significant changes in between the different timepoints

Article Snippet: CD62 E/P , R & D Systems , BBA1 , BBIG-E(13D5).

Techniques: Marker, Expressing

Correlation analysis of significant miRNA measurements (hsa-miR-19b-3p, hsa-miR-30d-5p, hsa-miR-374a-5p, hsa-miR-20a/20b-5p, hsa-miR-24-3p) and CD62/P-selectin. The histograms on the diagonal show the distribution of each variable. The lower triangular panels depict scatter plots with fitted lines, illustrating the linear relationships between pairs of variables. The upper triangular panels display the correlation coefficients, with significance levels indicated by asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001)

Journal: BMC Neuroscience

Article Title: Exploring extracellular vesicle surface markers and microRNA regulation following remote ischemic conditioning in patients with stroke; a randomized-controlled pilot study

doi: 10.1186/s12868-025-00993-1

Figure Lengend Snippet: Correlation analysis of significant miRNA measurements (hsa-miR-19b-3p, hsa-miR-30d-5p, hsa-miR-374a-5p, hsa-miR-20a/20b-5p, hsa-miR-24-3p) and CD62/P-selectin. The histograms on the diagonal show the distribution of each variable. The lower triangular panels depict scatter plots with fitted lines, illustrating the linear relationships between pairs of variables. The upper triangular panels display the correlation coefficients, with significance levels indicated by asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001)

Article Snippet: CD62 E/P , R & D Systems , BBA1 , BBIG-E(13D5).

Techniques:

( A – C ): P-selectin expression on unstimulated ( A ), ADP-stimulated ( B ), and TRAP-stimulated ( C ) platelets of patients with sepsis and septic shock compared to healthy controls at T0, T1, and T2. Results are expressed as a % of P-selectin-positive platelets, identified as CD42 B-positive events. ( A ) T0 vs. CTRL: p bonf = 0.0006; T1 vs. CTRL: p bonf = 0.0006; T2 vs. CTRL: p bonf = 0.12; ( B ) T0 vs. CTRL: p bonf = 0.026; T1 vs. CTRL: p bonf = 0.056; T2 vs. CTRL: p bonf = 0.037; ( C ) n.s.= not significant. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are reported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05, ** p < 0.005. ns = no significance.

Journal: Pathogens

Article Title: Early Platelet Dysfunction in Sepsis: An ICU Pilot Study

doi: 10.3390/pathogens15020196

Figure Lengend Snippet: ( A – C ): P-selectin expression on unstimulated ( A ), ADP-stimulated ( B ), and TRAP-stimulated ( C ) platelets of patients with sepsis and septic shock compared to healthy controls at T0, T1, and T2. Results are expressed as a % of P-selectin-positive platelets, identified as CD42 B-positive events. ( A ) T0 vs. CTRL: p bonf = 0.0006; T1 vs. CTRL: p bonf = 0.0006; T2 vs. CTRL: p bonf = 0.12; ( B ) T0 vs. CTRL: p bonf = 0.026; T1 vs. CTRL: p bonf = 0.056; T2 vs. CTRL: p bonf = 0.037; ( C ) n.s.= not significant. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are reported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05, ** p < 0.005. ns = no significance.

Article Snippet: Measurement of soluble P-selectin and soluble CD40 ligand in serum was per-formed using the anti-human P-selectin (R&D System, Inc., Minneapolis, MN, USA) and human CD40L/TNFSF5 (R&D System, Inc., Minneapolis, MN, USA) immunoassay kits ac-cording to the manufacturer’s instructions.

Techniques: Expressing

( A , B ): Patient soluble CD40L ( A ) and soluble P-selectin ( B ) plasma levels at times T0, T1, and T2 compared to controls. ( A ) T0 vs. CTRL: p bonf = 0.05; T1 vs. CTRL: p bonf = 0.04; T2 vs. CTRL: p bonf = 0.018. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are re-ported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05. ns = no significance.

Journal: Pathogens

Article Title: Early Platelet Dysfunction in Sepsis: An ICU Pilot Study

doi: 10.3390/pathogens15020196

Figure Lengend Snippet: ( A , B ): Patient soluble CD40L ( A ) and soluble P-selectin ( B ) plasma levels at times T0, T1, and T2 compared to controls. ( A ) T0 vs. CTRL: p bonf = 0.05; T1 vs. CTRL: p bonf = 0.04; T2 vs. CTRL: p bonf = 0.018. Bonferroni correction was applied for all pairwise comparisons; p -values (p bonf ) are re-ported. Sample size: n = 10 at T0 and T2, n = 9 at T1. * p < 0.05. ns = no significance.

Article Snippet: Measurement of soluble P-selectin and soluble CD40 ligand in serum was per-formed using the anti-human P-selectin (R&D System, Inc., Minneapolis, MN, USA) and human CD40L/TNFSF5 (R&D System, Inc., Minneapolis, MN, USA) immunoassay kits ac-cording to the manufacturer’s instructions.

Techniques: Clinical Proteomics